• bitcoinBitcoin(BTC)$78,982.00-2.89%
  • ethereumEthereum(ETH)$2,274.39-3.71%
  • tetherTether(USDT)$1.00-0.05%
  • binancecoinBNB(BNB)$702.35-7.34%
  • rippleXRP(XRP)$1.25-6.05%
  • usd-coinUSDC(USDC)$1.00-0.03%
  • solanaSolana(SOL)$97.30-5.17%
  • tronTRON(TRX)$0.3440293.73%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.09%
  • HyperliquidHyperliquid(HYPE)$92.5113.90%
  • zcashZcash(ZEC)$1,258.44-4.21%
  • dogecoinDogecoin(DOGE)$0.076202-4.70%
  • moneroMonero(XMR)$618.842.96%
  • USDSUSDS(USDS)$1.00-0.15%
  • whitebitWhiteBIT Coin(WBT)$75.66-3.13%
  • leo-tokenLEO Token(LEO)$9.460.53%
  • chainlinkChainlink(LINK)$10.94-7.56%
  • cardanoCardano(ADA)$0.192843-6.59%
  • stellarStellar(XLM)$0.164268-5.13%
  • bitcoin-cashBitcoin Cash(BCH)$277.72-4.22%
  • nearNEAR Protocol(NEAR)$4.14-12.80%
  • RainRain(RAIN)$0.006755-3.23%
  • daiDai(DAI)$1.00-0.01%
  • Ethena USDeEthena USDe(USDE)$1.00-0.12%
  • litecoinLitecoin(LTC)$55.63-6.40%
  • uniswapUniswap(UNI)$6.51-10.57%
  • USD1USD1(USD1)$1.00-0.11%
  • CantonCanton(CC)$0.096589-4.42%
  • avalanche-2Avalanche(AVAX)$8.39-6.89%
  • suiSui(SUI)$0.89-6.61%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.18-4.71%
  • tether-goldTether Gold(XAUT)$4,011.24-0.89%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.069978-7.10%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.12%
  • BittensorBittensor(TAO)$238.86-7.28%
  • shiba-inuShiba Inu(SHIB)$0.000005-5.99%
  • quant-networkQuant(QNT)$183.57-8.29%
  • Ripple USDRipple USD(RLUSD)$1.00-0.08%
  • crypto-com-chainCronos(CRO)$0.051620-3.34%
  • EthenaEthena(ENA)$0.181769-13.52%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.04%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • okbOKB(OKB)$111.18-0.10%
  • BitwayBitway(BTW)$1.55-10.39%
  • MemeCoreMemeCore(M)$1.02-3.27%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$124.43-7.96%
  • OndoOndo(ONDO)$0.392329-7.14%
  • pepePepe(PEPE)$0.000005-10.43%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Zurn Elkay Water Solutions Corporation (ZWS) Q3 2025 Earnings Call Transcript

October 29, 2025
in Market & News
Reading Time: 3 mins read
A A
Zurn Elkay Water Solutions Corporation (ZWS) Q3 2025 Earnings Call Transcript
ShareShareShareShareShare

Q3: 2025-10-28 Earnings Summary

EPS of $0.43 beats by $0.03

 | Revenue of $455.40M (11.07% Y/Y) beats by $12.75M

Zurn Elkay Water Solutions Corporation (ZWS) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT

YOU MAY ALSO LIKE

WHO seeks answers and clarity over plague lab death in Russia

Stanford professor says he was in a ‘dream-like state’ after winning Nobel prize

Company Participants

Bryan Wendlandt – Director of FP&A
Todd Adams – CEO & Chairman
David Pauli – Chief Financial Officer

Conference Call Participants

Bryan Blair – Oppenheimer & Co. Inc., Research Division
Adam Farley – Stifel, Nicolaus & Company, Incorporated, Research Division
Michael Pesendorfer – Robert W. Baird & Co. Incorporated, Research Division
Edward Magi – BNP Paribas Exane, Research Division
David Tarantino – KeyBanc Capital Markets Inc., Research Division
Brett Linzey – Mizuho Securities USA LLC, Research Division

Presentation

Operator

Good morning, and welcome to the Zurn Elkay Water Solutions Corporation Third Quarter 2025 Earnings Results Conference Call, with Todd Adams, Chairman and Chief Executive Officer; David Pauli, Chief Financial Officer; and Bryan Wendlandt, Director of FP&A for Zurn Elkay Water Solutions. A replay of the conference call will be available as a webcast on the company’s Investor Relations website.

At this time, for opening remarks and introduction, I’ll turn the call over to Bryan Wendlandt.

Bryan Wendlandt
Director of FP&A

Good morning, everyone, and thanks for joining the call today. Before we begin, I’d like to remind everyone that this call contains certain forward-looking statements, which are subject to the safe harbor language outlined in our press release issued yesterday afternoon and in our filings with the SEC.

In addition, some comparisons will refer to non-GAAP measures. Our earnings release and SEC filings contain additional information about these non-GAAP measures, why we use them and why we believe they’re helpful to investors, and contain reconciliations to the corresponding GAAP information. Consistent with prior quarters, we will speak to certain non-GAAP metrics as we feel they provide a better understanding of our operating results. These measures are not a substitute for GAAP. We encourage you to review the GAAP information in our earnings release and in

Credit: Source link

ShareTweetSendSharePin

Related Posts

WHO seeks answers and clarity over plague lab death in Russia
Market & News

WHO seeks answers and clarity over plague lab death in Russia

October 29, 2026
Stanford professor says he was in a ‘dream-like state’ after winning Nobel prize
Market & News

Stanford professor says he was in a ‘dream-like state’ after winning Nobel prize

October 29, 2026
Protester grabbed by audience member at Texas Trump rally
Market & News

Protester grabbed by audience member at Texas Trump rally

October 29, 2026
Trump appears to clarify earlier remarks on L.A., San Diego
Market & News

Trump appears to clarify earlier remarks on L.A., San Diego

October 29, 2026
Next Post
Legal analyst explains where civil cases go after Combs sentencing

Legal analyst explains where civil cases go after Combs sentencing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Google DeepMind Introduces Gemini 4 Carbon, Its Top Model for Cyber Defense and Coding

Google DeepMind Introduces Gemini 4 Carbon, Its Top Model for Cyber Defense and Coding

October 28, 2026
Hurricane Isaias kills at least four people as millions are still under threat

Hurricane Isaias kills at least four people as millions are still under threat

October 28, 2026
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

October 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!